Pharmaceutical Medicine.:
The breadth of the pharmaceutical medicine can be daunting, but this book is designed to navigate a path through the speciality. Providing a broad overview of all topics relevant to the discipline of pharmaceutical medicine, it gives you the facts fast, in a user-friendly format, without having to d...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Weitere Verfasser: | , |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
[Oxford] :
Oxford University Press,
2013.
|
| Schriftenreihe: | Oxford specialist handbooks.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | The breadth of the pharmaceutical medicine can be daunting, but this book is designed to navigate a path through the speciality. Providing a broad overview of all topics relevant to the discipline of pharmaceutical medicine, it gives you the facts fast, in a user-friendly format, without having to dive through page upon page of dense text. With 136 chapters spread across 8 sections, the text offers a thorough grounding in issues ranging from medicines regulation to clinical trial design and data management. This makes it a useful revision aid for exams as well as giving you a taster of areas o. |
| Beschreibung: | 4.3 General principles of clinical trial protocols. |
| Beschreibung: | 1 online resource (473 pages) |
| Bibliographie: | Includes bibliographical references and index. |
| ISBN: | 0199609144 9780199609147 1299753272 9781299753273 9780191510397 0191510394 0191742775 9780191742774 |
Internformat
MARC
| LEADER | 00000cam a2200000Mu 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn990537291 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr |n|---||||| | ||
| 008 | 131209s2013 enk ob 001 0 eng d | ||
| 040 | |a LIP |b eng |e pn |c LIP |d OCLCO |d N$T |d YDXCP |d EBLCP |d IDEBK |d E7B |d MHW |d CDX |d DEBSZ |d OCLCF |d CUV |d KIJ |d STBDS |d LGG |d OCLCQ |d NJR |d OCLCO |d OCL |d OCLCA |d OCLCQ |d K6U |d OCLCQ |d UKAHL |d QGK |d OCLCO |d OCLCQ |d OCL |d OCLCQ |d OCLCO |d OCLCL | ||
| 019 | |a 854854023 |a 1241962583 |a 1264959609 | ||
| 020 | |a 0199609144 | ||
| 020 | |a 9780199609147 | ||
| 020 | |a 1299753272 | ||
| 020 | |a 9781299753273 | ||
| 020 | |a 9780191510397 | ||
| 020 | |a 0191510394 | ||
| 020 | |a 0191742775 | ||
| 020 | |a 9780191742774 | ||
| 035 | |a (OCoLC)990537291 |z (OCoLC)854854023 |z (OCoLC)1241962583 |z (OCoLC)1264959609 | ||
| 037 | |a 506578 |b MIL | ||
| 050 | 4 | |a RS122.95 .K384 2013 | |
| 072 | 7 | |a MED |x 023000 |2 bisacsh | |
| 072 | 7 | |a MED |x 058170 |2 bisacsh | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 072 | 7 | |a MED |x 072000 |2 bisacsh | |
| 082 | 7 | |a 615.1 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Kilcoyne, Adrian. | |
| 245 | 1 | 0 | |a Pharmaceutical Medicine. |
| 246 | 3 | |a Oxford Specialist Handbooks | |
| 264 | 1 | |a [Oxford] : |b Oxford University Press, |c 2013. | |
| 300 | |a 1 online resource (473 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Oxford Specialist Handbooks | |
| 588 | 0 | |a Print version record. | |
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | |a Cover; Contents; Preface; Contributors; Abbreviations; Section 1: Discovery of new medicines; 1.1 Intellectual property in discovery; 1.2 Targeted drug discovery: receptor-based approaches; 1.3 In vitro and in vivo testing of new compounds; 1.4 Lead optimization; 1.5 Natural products and herbal medicines; Section 2: Medicines regulation; 2.1 General principles of medicines regulation; 2.2 Medicines regulation in the UK; 2.3 Medicines regulation in the EU; 2.4 The European Medicines Agency and Heads of Medicines Agencies. | |
| 505 | 8 | |a 2.5 The European Directorate for the Quality of Medicines and HealthCare, European Pharmacopoeia, and British Pharmacopoeia2.6 The Food and Drug Administration; 2.7 Health Canada; 2.8 Medsafe and the Therapeutic Goods Administration; 2.9 Medicines regulation in Japan; 2.10 Medicines regulation in China; 2.11 Medical device regulation; 2.12 Clinical trials regulation; 2.13 Good clinical practice; 2.14 Good laboratory practice and good clinical laboratory practice; 2.15 Good manufacturing practice; 2.16 The Ethics Committee (EU); 2.17 The Institutional Review Board (US). | |
| 505 | 8 | |a 2.18 Marketing authorization applications and updating and maintaining licences2.19 The International Conference on Harmonisation; 2.20 Common technical document; 2.21 Medicinal product information in the European Union; 2.22 Summary of product characteristics; 2.23 Orphan drugs; 2.24 Paediatric investigational plans; 2.25 Regulatory requirements for pharmacovigilance; 2.26 Overview of reporting of adverse drug reactions; 2.27 Non-prescription drugs; 2.28 Provision of unlicensed medicines; 2.29 Reclassification of medicines; 2.30 Parallel imports; Section 3: Clinical pharmacology. | |
| 505 | 8 | |a 3.1 Absorption, distribution, metabolism, and excretion3.2 Volume of distribution, clearance, half-life; 3.3 Pre-clinical aspects of pharmacokinetics; 3.4 Non-clinical data; 3.5 Clinical aspects of pharmacokinetics; 3.6 Dose-response relationship; 3.7 Proof of concept studies; 3.8 Reproductive toxicity studies; 3.9 Immunotoxicity testing; 3.10 Carcinogenicity; 3.11 Genotoxicity testing; 3.12 Local tolerance; 3.13 Acute toxicity; 3.14 Studies: objectives, design, conduct, and analysis; 3.15 Populations for exploratory studies and planning of exploratory studies; 3.16 Pharmacodynamic endpoints. | |
| 505 | 8 | |a 3.17 Bioavailability and bioequivalence3.18 Evaluation of safety and tolerability; 3.19 Hypersensitivity reactions; 3.20 Drug-drug interactions; 3.21 Ethics in research: basic principles, Declaration of Helsinki, and Council for International Organizations of Medical Sciences; 3.22 Disease models; 3.23 Biomarkers; 3.24 Pharmacogenetics; 3.25 Population pharmacokinetics; 3.26 Small molecules and biologicals: safety and pharmacology requirements; Section 4: Clinical development; 4.1 Requirements for licensing a new medicinal product; 4.2 Regulatory guidance. | |
| 500 | |a 4.3 General principles of clinical trial protocols. | ||
| 520 | |a The breadth of the pharmaceutical medicine can be daunting, but this book is designed to navigate a path through the speciality. Providing a broad overview of all topics relevant to the discipline of pharmaceutical medicine, it gives you the facts fast, in a user-friendly format, without having to dive through page upon page of dense text. With 136 chapters spread across 8 sections, the text offers a thorough grounding in issues ranging from medicines regulation to clinical trial design and data management. This makes it a useful revision aid for exams as well as giving you a taster of areas o. | ||
| 546 | |a English. | ||
| 588 | 0 | |a Online resource; title from home page (viewed on July 8, 2013). | |
| 650 | 0 | |a Clinical pharmacology. |0 http://id.loc.gov/authorities/subjects/sh90000174 | |
| 650 | 0 | |a Drug development. |0 http://id.loc.gov/authorities/subjects/sh97007921 | |
| 650 | 0 | |a Medical personnel. |0 http://id.loc.gov/authorities/subjects/sh85082982 | |
| 650 | 0 | |a Therapeutics. |0 http://id.loc.gov/authorities/subjects/sh85134723 | |
| 650 | 0 | |a Drugs. |0 http://id.loc.gov/authorities/subjects/sh85039719 | |
| 650 | 0 | |a Chemotherapy. |0 http://id.loc.gov/authorities/subjects/sh85023041 | |
| 650 | 0 | |a Pharmacy. |0 http://id.loc.gov/authorities/subjects/sh85100603 | |
| 650 | 2 | |a Chemicals and Drugs | |
| 650 | 2 | |a Health Occupations | |
| 650 | 2 | |a Therapeutics | |
| 650 | 2 | |a Analytical, Diagnostic and Therapeutic Techniques and Equipment | |
| 650 | 2 | |a Disciplines and Occupations | |
| 650 | 2 | |a Pharmaceutical Preparations | |
| 650 | 2 | |a Drug Therapy | |
| 650 | 2 | |a Pharmacy | |
| 650 | 2 | |a Pharmacology, Clinical |0 https://id.nlm.nih.gov/mesh/D010601 | |
| 650 | 6 | |a Pharmacologie clinique. | |
| 650 | 6 | |a Médicaments |x Développement. | |
| 650 | 6 | |a Personnel médical. | |
| 650 | 6 | |a Thérapeutique. | |
| 650 | 6 | |a Médicaments. | |
| 650 | 6 | |a Chimiothérapie. | |
| 650 | 6 | |a Pharmacie. | |
| 650 | 7 | |a pharmacies (health facilities ) |2 aat | |
| 650 | 7 | |a treating (health care function) |2 aat | |
| 650 | 7 | |a pharmacy (discipline) |2 aat | |
| 650 | 7 | |a MEDICAL |x Drug Guides. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Nursing |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Pharmacy. |2 bisacsh | |
| 650 | 7 | |a Therapeutics |2 fast | |
| 650 | 7 | |a Pharmacy |2 fast | |
| 650 | 7 | |a Medical personnel |2 fast | |
| 650 | 7 | |a Drugs |2 fast | |
| 650 | 7 | |a Chemotherapy |2 fast | |
| 650 | 7 | |a Clinical pharmacology |2 fast | |
| 650 | 7 | |a Drug development |2 fast | |
| 700 | 1 | |a Ambery, Phil. | |
| 700 | 1 | |a O'Connor, Daniel. | |
| 758 | |i has work: |a Pharmaceutical medicine (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGbKxmvbTqQbCDgMk9VX3P |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Pharmaceutical medicine |z 9780199609147 |w (OCoLC)825557405 |
| 830 | 0 | |a Oxford specialist handbooks. |0 http://id.loc.gov/authorities/names/n2007182886 | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=615422 |3 Volltext |
| 938 | |a Askews and Holts Library Services |b ASKH |n AH25954560 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL7036301 | ||
| 938 | |a Askews and Holts Library Services |b ASKH |n AH25954788 | ||
| 938 | |a Coutts Information Services |b COUT |n 26007546 | ||
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL1336482 | ||
| 938 | |a ebrary |b EBRY |n ebr10738623 | ||
| 938 | |a EBSCOhost |b EBSC |n 615422 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n cis26007546 | ||
| 938 | |a Oxford University Press USA |b OUPR |n EDZ0000131200 | ||
| 938 | |a YBP Library Services |b YANK |n 10887198 | ||
| 938 | |a YBP Library Services |b YANK |n 12890131 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn990537291 |
|---|---|
| _version_ | 1816882392667783168 |
| adam_text | |
| any_adam_object | |
| author | Kilcoyne, Adrian |
| author2 | Ambery, Phil O'Connor, Daniel |
| author2_role | |
| author2_variant | p a pa d o do |
| author_facet | Kilcoyne, Adrian Ambery, Phil O'Connor, Daniel |
| author_role | |
| author_sort | Kilcoyne, Adrian |
| author_variant | a k ak |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RS122 |
| callnumber-raw | RS122.95 .K384 2013 |
| callnumber-search | RS122.95 .K384 2013 |
| callnumber-sort | RS 3122.95 K384 42013 |
| callnumber-subject | RS - Pharmacy |
| collection | ZDB-4-EBA |
| contents | Cover; Contents; Preface; Contributors; Abbreviations; Section 1: Discovery of new medicines; 1.1 Intellectual property in discovery; 1.2 Targeted drug discovery: receptor-based approaches; 1.3 In vitro and in vivo testing of new compounds; 1.4 Lead optimization; 1.5 Natural products and herbal medicines; Section 2: Medicines regulation; 2.1 General principles of medicines regulation; 2.2 Medicines regulation in the UK; 2.3 Medicines regulation in the EU; 2.4 The European Medicines Agency and Heads of Medicines Agencies. 2.5 The European Directorate for the Quality of Medicines and HealthCare, European Pharmacopoeia, and British Pharmacopoeia2.6 The Food and Drug Administration; 2.7 Health Canada; 2.8 Medsafe and the Therapeutic Goods Administration; 2.9 Medicines regulation in Japan; 2.10 Medicines regulation in China; 2.11 Medical device regulation; 2.12 Clinical trials regulation; 2.13 Good clinical practice; 2.14 Good laboratory practice and good clinical laboratory practice; 2.15 Good manufacturing practice; 2.16 The Ethics Committee (EU); 2.17 The Institutional Review Board (US). 2.18 Marketing authorization applications and updating and maintaining licences2.19 The International Conference on Harmonisation; 2.20 Common technical document; 2.21 Medicinal product information in the European Union; 2.22 Summary of product characteristics; 2.23 Orphan drugs; 2.24 Paediatric investigational plans; 2.25 Regulatory requirements for pharmacovigilance; 2.26 Overview of reporting of adverse drug reactions; 2.27 Non-prescription drugs; 2.28 Provision of unlicensed medicines; 2.29 Reclassification of medicines; 2.30 Parallel imports; Section 3: Clinical pharmacology. 3.1 Absorption, distribution, metabolism, and excretion3.2 Volume of distribution, clearance, half-life; 3.3 Pre-clinical aspects of pharmacokinetics; 3.4 Non-clinical data; 3.5 Clinical aspects of pharmacokinetics; 3.6 Dose-response relationship; 3.7 Proof of concept studies; 3.8 Reproductive toxicity studies; 3.9 Immunotoxicity testing; 3.10 Carcinogenicity; 3.11 Genotoxicity testing; 3.12 Local tolerance; 3.13 Acute toxicity; 3.14 Studies: objectives, design, conduct, and analysis; 3.15 Populations for exploratory studies and planning of exploratory studies; 3.16 Pharmacodynamic endpoints. 3.17 Bioavailability and bioequivalence3.18 Evaluation of safety and tolerability; 3.19 Hypersensitivity reactions; 3.20 Drug-drug interactions; 3.21 Ethics in research: basic principles, Declaration of Helsinki, and Council for International Organizations of Medical Sciences; 3.22 Disease models; 3.23 Biomarkers; 3.24 Pharmacogenetics; 3.25 Population pharmacokinetics; 3.26 Small molecules and biologicals: safety and pharmacology requirements; Section 4: Clinical development; 4.1 Requirements for licensing a new medicinal product; 4.2 Regulatory guidance. |
| ctrlnum | (OCoLC)990537291 |
| dewey-full | 615.1 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.1 |
| dewey-search | 615.1 |
| dewey-sort | 3615.1 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>08272cam a2201225Mu 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn990537291</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |n|---|||||</controlfield><controlfield tag="008">131209s2013 enk ob 001 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">LIP</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">LIP</subfield><subfield code="d">OCLCO</subfield><subfield code="d">N$T</subfield><subfield code="d">YDXCP</subfield><subfield code="d">EBLCP</subfield><subfield code="d">IDEBK</subfield><subfield code="d">E7B</subfield><subfield code="d">MHW</subfield><subfield code="d">CDX</subfield><subfield code="d">DEBSZ</subfield><subfield code="d">OCLCF</subfield><subfield code="d">CUV</subfield><subfield code="d">KIJ</subfield><subfield code="d">STBDS</subfield><subfield code="d">LGG</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">NJR</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">K6U</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">UKAHL</subfield><subfield code="d">QGK</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">854854023</subfield><subfield code="a">1241962583</subfield><subfield code="a">1264959609</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0199609144</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780199609147</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1299753272</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781299753273</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780191510397</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0191510394</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0191742775</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780191742774</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)990537291</subfield><subfield code="z">(OCoLC)854854023</subfield><subfield code="z">(OCoLC)1241962583</subfield><subfield code="z">(OCoLC)1264959609</subfield></datafield><datafield tag="037" ind1=" " ind2=" "><subfield code="a">506578</subfield><subfield code="b">MIL</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RS122.95 .K384 2013</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">023000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">058170</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">071000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">072000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">615.1</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Kilcoyne, Adrian.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmaceutical Medicine.</subfield></datafield><datafield tag="246" ind1="3" ind2=" "><subfield code="a">Oxford Specialist Handbooks</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">[Oxford] :</subfield><subfield code="b">Oxford University Press,</subfield><subfield code="c">2013.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (473 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Oxford Specialist Handbooks</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Cover; Contents; Preface; Contributors; Abbreviations; Section 1: Discovery of new medicines; 1.1 Intellectual property in discovery; 1.2 Targeted drug discovery: receptor-based approaches; 1.3 In vitro and in vivo testing of new compounds; 1.4 Lead optimization; 1.5 Natural products and herbal medicines; Section 2: Medicines regulation; 2.1 General principles of medicines regulation; 2.2 Medicines regulation in the UK; 2.3 Medicines regulation in the EU; 2.4 The European Medicines Agency and Heads of Medicines Agencies.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">2.5 The European Directorate for the Quality of Medicines and HealthCare, European Pharmacopoeia, and British Pharmacopoeia2.6 The Food and Drug Administration; 2.7 Health Canada; 2.8 Medsafe and the Therapeutic Goods Administration; 2.9 Medicines regulation in Japan; 2.10 Medicines regulation in China; 2.11 Medical device regulation; 2.12 Clinical trials regulation; 2.13 Good clinical practice; 2.14 Good laboratory practice and good clinical laboratory practice; 2.15 Good manufacturing practice; 2.16 The Ethics Committee (EU); 2.17 The Institutional Review Board (US).</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">2.18 Marketing authorization applications and updating and maintaining licences2.19 The International Conference on Harmonisation; 2.20 Common technical document; 2.21 Medicinal product information in the European Union; 2.22 Summary of product characteristics; 2.23 Orphan drugs; 2.24 Paediatric investigational plans; 2.25 Regulatory requirements for pharmacovigilance; 2.26 Overview of reporting of adverse drug reactions; 2.27 Non-prescription drugs; 2.28 Provision of unlicensed medicines; 2.29 Reclassification of medicines; 2.30 Parallel imports; Section 3: Clinical pharmacology.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">3.1 Absorption, distribution, metabolism, and excretion3.2 Volume of distribution, clearance, half-life; 3.3 Pre-clinical aspects of pharmacokinetics; 3.4 Non-clinical data; 3.5 Clinical aspects of pharmacokinetics; 3.6 Dose-response relationship; 3.7 Proof of concept studies; 3.8 Reproductive toxicity studies; 3.9 Immunotoxicity testing; 3.10 Carcinogenicity; 3.11 Genotoxicity testing; 3.12 Local tolerance; 3.13 Acute toxicity; 3.14 Studies: objectives, design, conduct, and analysis; 3.15 Populations for exploratory studies and planning of exploratory studies; 3.16 Pharmacodynamic endpoints.</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">3.17 Bioavailability and bioequivalence3.18 Evaluation of safety and tolerability; 3.19 Hypersensitivity reactions; 3.20 Drug-drug interactions; 3.21 Ethics in research: basic principles, Declaration of Helsinki, and Council for International Organizations of Medical Sciences; 3.22 Disease models; 3.23 Biomarkers; 3.24 Pharmacogenetics; 3.25 Population pharmacokinetics; 3.26 Small molecules and biologicals: safety and pharmacology requirements; Section 4: Clinical development; 4.1 Requirements for licensing a new medicinal product; 4.2 Regulatory guidance.</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">4.3 General principles of clinical trial protocols.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The breadth of the pharmaceutical medicine can be daunting, but this book is designed to navigate a path through the speciality. Providing a broad overview of all topics relevant to the discipline of pharmaceutical medicine, it gives you the facts fast, in a user-friendly format, without having to dive through page upon page of dense text. With 136 chapters spread across 8 sections, the text offers a thorough grounding in issues ranging from medicines regulation to clinical trial design and data management. This makes it a useful revision aid for exams as well as giving you a taster of areas o.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Online resource; title from home page (viewed on July 8, 2013).</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Clinical pharmacology.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh90000174</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug development.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh97007921</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical personnel.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85082982</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Therapeutics.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85134723</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85039719</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Chemotherapy.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85023041</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmacy.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85100603</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Chemicals and Drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Health Occupations</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Therapeutics</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Analytical, Diagnostic and Therapeutic Techniques and Equipment</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Disciplines and Occupations</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Pharmaceutical Preparations</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Drug Therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Pharmacy</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Pharmacology, Clinical</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D010601</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Pharmacologie clinique.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médicaments</subfield><subfield code="x">Développement.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Personnel médical.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Thérapeutique.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médicaments.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Chimiothérapie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Pharmacie.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">pharmacies (health facilities )</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">treating (health care function)</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">pharmacy (discipline)</subfield><subfield code="2">aat</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Drug Guides.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Nursing</subfield><subfield code="x">Pharmacology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Pharmacology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Pharmacy.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Therapeutics</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmacy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medical personnel</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemotherapy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Clinical pharmacology</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug development</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ambery, Phil.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">O'Connor, Daniel.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Pharmaceutical medicine (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCGbKxmvbTqQbCDgMk9VX3P</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Pharmaceutical medicine</subfield><subfield code="z">9780199609147</subfield><subfield code="w">(OCoLC)825557405</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Oxford specialist handbooks.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n2007182886</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=615422</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH25954560</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL7036301</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Askews and Holts Library Services</subfield><subfield code="b">ASKH</subfield><subfield code="n">AH25954788</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Coutts Information Services</subfield><subfield code="b">COUT</subfield><subfield code="n">26007546</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL1336482</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10738623</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">615422</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest MyiLibrary Digital eBook Collection</subfield><subfield code="b">IDEB</subfield><subfield code="n">cis26007546</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Oxford University Press USA</subfield><subfield code="b">OUPR</subfield><subfield code="n">EDZ0000131200</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">10887198</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">12890131</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-ocn990537291 |
| illustrated | Not Illustrated |
| indexdate | 2024-11-27T13:27:53Z |
| institution | BVB |
| isbn | 0199609144 9780199609147 1299753272 9781299753273 9780191510397 0191510394 0191742775 9780191742774 |
| language | English |
| oclc_num | 990537291 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (473 pages) |
| psigel | ZDB-4-EBA |
| publishDate | 2013 |
| publishDateSearch | 2013 |
| publishDateSort | 2013 |
| publisher | Oxford University Press, |
| record_format | marc |
| series | Oxford specialist handbooks. |
| series2 | Oxford Specialist Handbooks |
| spelling | Kilcoyne, Adrian. Pharmaceutical Medicine. Oxford Specialist Handbooks [Oxford] : Oxford University Press, 2013. 1 online resource (473 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Print version record. Includes bibliographical references and index. Cover; Contents; Preface; Contributors; Abbreviations; Section 1: Discovery of new medicines; 1.1 Intellectual property in discovery; 1.2 Targeted drug discovery: receptor-based approaches; 1.3 In vitro and in vivo testing of new compounds; 1.4 Lead optimization; 1.5 Natural products and herbal medicines; Section 2: Medicines regulation; 2.1 General principles of medicines regulation; 2.2 Medicines regulation in the UK; 2.3 Medicines regulation in the EU; 2.4 The European Medicines Agency and Heads of Medicines Agencies. 2.5 The European Directorate for the Quality of Medicines and HealthCare, European Pharmacopoeia, and British Pharmacopoeia2.6 The Food and Drug Administration; 2.7 Health Canada; 2.8 Medsafe and the Therapeutic Goods Administration; 2.9 Medicines regulation in Japan; 2.10 Medicines regulation in China; 2.11 Medical device regulation; 2.12 Clinical trials regulation; 2.13 Good clinical practice; 2.14 Good laboratory practice and good clinical laboratory practice; 2.15 Good manufacturing practice; 2.16 The Ethics Committee (EU); 2.17 The Institutional Review Board (US). 2.18 Marketing authorization applications and updating and maintaining licences2.19 The International Conference on Harmonisation; 2.20 Common technical document; 2.21 Medicinal product information in the European Union; 2.22 Summary of product characteristics; 2.23 Orphan drugs; 2.24 Paediatric investigational plans; 2.25 Regulatory requirements for pharmacovigilance; 2.26 Overview of reporting of adverse drug reactions; 2.27 Non-prescription drugs; 2.28 Provision of unlicensed medicines; 2.29 Reclassification of medicines; 2.30 Parallel imports; Section 3: Clinical pharmacology. 3.1 Absorption, distribution, metabolism, and excretion3.2 Volume of distribution, clearance, half-life; 3.3 Pre-clinical aspects of pharmacokinetics; 3.4 Non-clinical data; 3.5 Clinical aspects of pharmacokinetics; 3.6 Dose-response relationship; 3.7 Proof of concept studies; 3.8 Reproductive toxicity studies; 3.9 Immunotoxicity testing; 3.10 Carcinogenicity; 3.11 Genotoxicity testing; 3.12 Local tolerance; 3.13 Acute toxicity; 3.14 Studies: objectives, design, conduct, and analysis; 3.15 Populations for exploratory studies and planning of exploratory studies; 3.16 Pharmacodynamic endpoints. 3.17 Bioavailability and bioequivalence3.18 Evaluation of safety and tolerability; 3.19 Hypersensitivity reactions; 3.20 Drug-drug interactions; 3.21 Ethics in research: basic principles, Declaration of Helsinki, and Council for International Organizations of Medical Sciences; 3.22 Disease models; 3.23 Biomarkers; 3.24 Pharmacogenetics; 3.25 Population pharmacokinetics; 3.26 Small molecules and biologicals: safety and pharmacology requirements; Section 4: Clinical development; 4.1 Requirements for licensing a new medicinal product; 4.2 Regulatory guidance. 4.3 General principles of clinical trial protocols. The breadth of the pharmaceutical medicine can be daunting, but this book is designed to navigate a path through the speciality. Providing a broad overview of all topics relevant to the discipline of pharmaceutical medicine, it gives you the facts fast, in a user-friendly format, without having to dive through page upon page of dense text. With 136 chapters spread across 8 sections, the text offers a thorough grounding in issues ranging from medicines regulation to clinical trial design and data management. This makes it a useful revision aid for exams as well as giving you a taster of areas o. English. Online resource; title from home page (viewed on July 8, 2013). Clinical pharmacology. http://id.loc.gov/authorities/subjects/sh90000174 Drug development. http://id.loc.gov/authorities/subjects/sh97007921 Medical personnel. http://id.loc.gov/authorities/subjects/sh85082982 Therapeutics. http://id.loc.gov/authorities/subjects/sh85134723 Drugs. http://id.loc.gov/authorities/subjects/sh85039719 Chemotherapy. http://id.loc.gov/authorities/subjects/sh85023041 Pharmacy. http://id.loc.gov/authorities/subjects/sh85100603 Chemicals and Drugs Health Occupations Therapeutics Analytical, Diagnostic and Therapeutic Techniques and Equipment Disciplines and Occupations Pharmaceutical Preparations Drug Therapy Pharmacy Pharmacology, Clinical https://id.nlm.nih.gov/mesh/D010601 Pharmacologie clinique. Médicaments Développement. Personnel médical. Thérapeutique. Médicaments. Chimiothérapie. Pharmacie. pharmacies (health facilities ) aat treating (health care function) aat pharmacy (discipline) aat MEDICAL Drug Guides. bisacsh MEDICAL Nursing Pharmacology. bisacsh MEDICAL Pharmacology. bisacsh MEDICAL Pharmacy. bisacsh Therapeutics fast Pharmacy fast Medical personnel fast Drugs fast Chemotherapy fast Clinical pharmacology fast Drug development fast Ambery, Phil. O'Connor, Daniel. has work: Pharmaceutical medicine (Text) https://id.oclc.org/worldcat/entity/E39PCGbKxmvbTqQbCDgMk9VX3P https://id.oclc.org/worldcat/ontology/hasWork Print version: Pharmaceutical medicine 9780199609147 (OCoLC)825557405 Oxford specialist handbooks. http://id.loc.gov/authorities/names/n2007182886 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=615422 Volltext |
| spellingShingle | Kilcoyne, Adrian Pharmaceutical Medicine. Oxford specialist handbooks. Cover; Contents; Preface; Contributors; Abbreviations; Section 1: Discovery of new medicines; 1.1 Intellectual property in discovery; 1.2 Targeted drug discovery: receptor-based approaches; 1.3 In vitro and in vivo testing of new compounds; 1.4 Lead optimization; 1.5 Natural products and herbal medicines; Section 2: Medicines regulation; 2.1 General principles of medicines regulation; 2.2 Medicines regulation in the UK; 2.3 Medicines regulation in the EU; 2.4 The European Medicines Agency and Heads of Medicines Agencies. 2.5 The European Directorate for the Quality of Medicines and HealthCare, European Pharmacopoeia, and British Pharmacopoeia2.6 The Food and Drug Administration; 2.7 Health Canada; 2.8 Medsafe and the Therapeutic Goods Administration; 2.9 Medicines regulation in Japan; 2.10 Medicines regulation in China; 2.11 Medical device regulation; 2.12 Clinical trials regulation; 2.13 Good clinical practice; 2.14 Good laboratory practice and good clinical laboratory practice; 2.15 Good manufacturing practice; 2.16 The Ethics Committee (EU); 2.17 The Institutional Review Board (US). 2.18 Marketing authorization applications and updating and maintaining licences2.19 The International Conference on Harmonisation; 2.20 Common technical document; 2.21 Medicinal product information in the European Union; 2.22 Summary of product characteristics; 2.23 Orphan drugs; 2.24 Paediatric investigational plans; 2.25 Regulatory requirements for pharmacovigilance; 2.26 Overview of reporting of adverse drug reactions; 2.27 Non-prescription drugs; 2.28 Provision of unlicensed medicines; 2.29 Reclassification of medicines; 2.30 Parallel imports; Section 3: Clinical pharmacology. 3.1 Absorption, distribution, metabolism, and excretion3.2 Volume of distribution, clearance, half-life; 3.3 Pre-clinical aspects of pharmacokinetics; 3.4 Non-clinical data; 3.5 Clinical aspects of pharmacokinetics; 3.6 Dose-response relationship; 3.7 Proof of concept studies; 3.8 Reproductive toxicity studies; 3.9 Immunotoxicity testing; 3.10 Carcinogenicity; 3.11 Genotoxicity testing; 3.12 Local tolerance; 3.13 Acute toxicity; 3.14 Studies: objectives, design, conduct, and analysis; 3.15 Populations for exploratory studies and planning of exploratory studies; 3.16 Pharmacodynamic endpoints. 3.17 Bioavailability and bioequivalence3.18 Evaluation of safety and tolerability; 3.19 Hypersensitivity reactions; 3.20 Drug-drug interactions; 3.21 Ethics in research: basic principles, Declaration of Helsinki, and Council for International Organizations of Medical Sciences; 3.22 Disease models; 3.23 Biomarkers; 3.24 Pharmacogenetics; 3.25 Population pharmacokinetics; 3.26 Small molecules and biologicals: safety and pharmacology requirements; Section 4: Clinical development; 4.1 Requirements for licensing a new medicinal product; 4.2 Regulatory guidance. Clinical pharmacology. http://id.loc.gov/authorities/subjects/sh90000174 Drug development. http://id.loc.gov/authorities/subjects/sh97007921 Medical personnel. http://id.loc.gov/authorities/subjects/sh85082982 Therapeutics. http://id.loc.gov/authorities/subjects/sh85134723 Drugs. http://id.loc.gov/authorities/subjects/sh85039719 Chemotherapy. http://id.loc.gov/authorities/subjects/sh85023041 Pharmacy. http://id.loc.gov/authorities/subjects/sh85100603 Chemicals and Drugs Health Occupations Therapeutics Analytical, Diagnostic and Therapeutic Techniques and Equipment Disciplines and Occupations Pharmaceutical Preparations Drug Therapy Pharmacy Pharmacology, Clinical https://id.nlm.nih.gov/mesh/D010601 Pharmacologie clinique. Médicaments Développement. Personnel médical. Thérapeutique. Médicaments. Chimiothérapie. Pharmacie. pharmacies (health facilities ) aat treating (health care function) aat pharmacy (discipline) aat MEDICAL Drug Guides. bisacsh MEDICAL Nursing Pharmacology. bisacsh MEDICAL Pharmacology. bisacsh MEDICAL Pharmacy. bisacsh Therapeutics fast Pharmacy fast Medical personnel fast Drugs fast Chemotherapy fast Clinical pharmacology fast Drug development fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh90000174 http://id.loc.gov/authorities/subjects/sh97007921 http://id.loc.gov/authorities/subjects/sh85082982 http://id.loc.gov/authorities/subjects/sh85134723 http://id.loc.gov/authorities/subjects/sh85039719 http://id.loc.gov/authorities/subjects/sh85023041 http://id.loc.gov/authorities/subjects/sh85100603 https://id.nlm.nih.gov/mesh/D010601 |
| title | Pharmaceutical Medicine. |
| title_alt | Oxford Specialist Handbooks |
| title_auth | Pharmaceutical Medicine. |
| title_exact_search | Pharmaceutical Medicine. |
| title_full | Pharmaceutical Medicine. |
| title_fullStr | Pharmaceutical Medicine. |
| title_full_unstemmed | Pharmaceutical Medicine. |
| title_short | Pharmaceutical Medicine. |
| title_sort | pharmaceutical medicine |
| topic | Clinical pharmacology. http://id.loc.gov/authorities/subjects/sh90000174 Drug development. http://id.loc.gov/authorities/subjects/sh97007921 Medical personnel. http://id.loc.gov/authorities/subjects/sh85082982 Therapeutics. http://id.loc.gov/authorities/subjects/sh85134723 Drugs. http://id.loc.gov/authorities/subjects/sh85039719 Chemotherapy. http://id.loc.gov/authorities/subjects/sh85023041 Pharmacy. http://id.loc.gov/authorities/subjects/sh85100603 Chemicals and Drugs Health Occupations Therapeutics Analytical, Diagnostic and Therapeutic Techniques and Equipment Disciplines and Occupations Pharmaceutical Preparations Drug Therapy Pharmacy Pharmacology, Clinical https://id.nlm.nih.gov/mesh/D010601 Pharmacologie clinique. Médicaments Développement. Personnel médical. Thérapeutique. Médicaments. Chimiothérapie. Pharmacie. pharmacies (health facilities ) aat treating (health care function) aat pharmacy (discipline) aat MEDICAL Drug Guides. bisacsh MEDICAL Nursing Pharmacology. bisacsh MEDICAL Pharmacology. bisacsh MEDICAL Pharmacy. bisacsh Therapeutics fast Pharmacy fast Medical personnel fast Drugs fast Chemotherapy fast Clinical pharmacology fast Drug development fast |
| topic_facet | Clinical pharmacology. Drug development. Medical personnel. Therapeutics. Drugs. Chemotherapy. Pharmacy. Chemicals and Drugs Health Occupations Therapeutics Analytical, Diagnostic and Therapeutic Techniques and Equipment Disciplines and Occupations Pharmaceutical Preparations Drug Therapy Pharmacy Pharmacology, Clinical Pharmacologie clinique. Médicaments Développement. Personnel médical. Thérapeutique. Médicaments. Chimiothérapie. Pharmacie. pharmacies (health facilities ) treating (health care function) pharmacy (discipline) MEDICAL Drug Guides. MEDICAL Nursing Pharmacology. MEDICAL Pharmacology. MEDICAL Pharmacy. Medical personnel Drugs Chemotherapy Clinical pharmacology Drug development |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=615422 |
| work_keys_str_mv | AT kilcoyneadrian pharmaceuticalmedicine AT amberyphil pharmaceuticalmedicine AT oconnordaniel pharmaceuticalmedicine AT kilcoyneadrian oxfordspecialisthandbooks AT amberyphil oxfordspecialisthandbooks AT oconnordaniel oxfordspecialisthandbooks |